Getinge announced that it has acquired 100% of the shares in US-based Healthmark Industries Co. Inc., a provider of innovative instrument care and infection control consumables, for approximately $320 million. The acquisition expands Getinge’s presence within sterile reprocessing in the U.S. and facilitates a global expansion for Healthmark.
“Together we will offer a broad range of solutions to sterile processing departments in hospitals,” said Stéphane Le Roy, president Surgical Workflows at Getinge. “Healthmark’s position in the field of consumables for cleaning verification and packaging will be an ideal complement to our consumables, reprocessing capital equipment, and software solutions. The acquisition strengthens Getinge’s position in the infection prevention sector in the US, and our global customer reach in Europe and Asia will also accelerate Healthmark’s international development.”
Founded in 1969, Healthmark’s headquarters and main production facilities are located in Fraser, Michigan in the United States. Healthmark also has a facility in Bobigny, France. Globally, Healthmark employs approximately 400 employees.
“We are pleased with Healthmark being integrated into the Getinge family. This combination makes sense due to the minimal overlap in our product portfolios,” said Mark Basile, president and CEO of Healthmark. “By bringing together our strengths, we are well positioned to better serve our customers, gain greater control over our supply chain and finished products, and expand our reach outside the United States.”
The acquisition has been financed through cash on hand and existing credit facilities. Getinge expects to have fully integrated Healthmark by the end of 2024 and anticipates no material integration costs in 2023 and 2024. The acquisition is not expected to have a material impact on Getinge’s operating profit and earnings per share in 2023.